Meeting with Gabriela Tschirkova (Cabinet of Commissioner Valdis Dombrovskis)

3 Nov 2025 · Simplification: Urban Wastewater Treatment Directive (UWTD)

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) 1107/2009, Regulation (EC) No 396/2005, Regulation (EU) 528/2012, Regulation (EC) 1831/2003, Regulation (EC) No 852/2004, Regulation (EC) No 853/2004, Regulation 1099/2009, Regulation (EC) No 999/2001, Regulation (EC) No 1069/2009, Regulation (EU) 2017/625 and Directive 98/58/EC, as regards simplifying and clarifying food and feed safety requirements

13 Oct 2025

Meeting with Florika Fink-Hooijer (Director-General Health Emergency Preparedness and Response Authority)

18 Sept 2025 · Exchange on DG HERA’s work, in particular focus on the EU’s health resilience and the recently adopted MCM strategy

Meeting with Olivér Várhelyi (Commissioner) and 2 other attendees

18 Sept 2025 · Current relevant legislative files and geopolitical health trends

Meeting with Ekaterina Zaharieva (Commissioner) and 1 other attendee

18 Sept 2025 · Exchange on the pharma industry and the hurdles they face.

Response to Commission Communication on a EU Cardiovascular Health Plan

17 Sept 2025

Meeting with Jutta Paulus (Member of the European Parliament)

2 Sept 2025 · Pharmaindustrie und kommunale Abwasserrichtlinie

Meeting with Marion Walsmann (Member of the European Parliament, Rapporteur for opinion)

24 Jul 2025 · CMA

Meeting with Oliver Schenk (Member of the European Parliament, Rapporteur for opinion)

1 Jul 2025 · Critical Medicines Act

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Hildegard Bentele (Member of the European Parliament, Shadow rapporteur)

11 Jun 2025 · Surface water and groundwater pollutants

Meeting with Jens Gieseke (Member of the European Parliament)

10 Jun 2025 · Austausch zu EU Politik

Response to Communication on the EU Stockpiling Strategy

9 May 2025

Meeting with Angelika Niebler (Member of the European Parliament) and Merck Sharp Dohme Europe Belgium SRL

15 Apr 2025 · European health policies

Meeting with Oliver Schenk (Member of the European Parliament)

2 Apr 2025 · Pharmaindustrie in Europa

Meeting with Manuela Ripa (Member of the European Parliament)

20 Mar 2025 · Health topics

Meeting with Jan Ceyssens (Cabinet of Commissioner Jessika Roswall)

20 Mar 2025 · Presentation of the industry’s views on the potential costs and impact of the extended producer responsibility (EPR) scheme introduced in the urban wastewater directive (in force)

Response to Evaluation of Directive 2014/23/EU on the award of concessions contracts, Directive 2014/24/EU on public procurement, and Directive 2014/25/EU on procurement by entities operating in the water, energy, transport and postal services sectors

7 Mar 2025

Response to Critical Medicines Act

27 Feb 2025

Meeting with Peter Liese (Member of the European Parliament) and 3 other interest representatives

29 Jan 2025 · Austausch

Meeting with Svenja Hahn (Member of the European Parliament) and 16 other interest representatives

24 Jan 2025 · Exchange on Green Claims

Meeting with Michel Sponar (Acting Head of Unit Environment)

15 Jan 2025 · Discussion on the implementation of the recast UWWTD, with a focus on Extended Producer Responsibility (Article 9)

Meeting with Hildegard Bentele (Member of the European Parliament, Shadow rapporteur)

17 Dec 2024 · Surface water and groundwater pollutants

Meeting with Peter Liese (Member of the European Parliament) and Bayer AG

12 Dec 2024 · Austausch

Meeting with Andrea Wechsler (Member of the European Parliament) and Zimmer Biomet Holdings

3 Dec 2024 · EU Environmental Policy

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

29 Oct 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

28 Mar 2024

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

28 Feb 2024

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 2 other interest representatives

14 Feb 2024 · Directive on Medicinal products for human use

Meeting with Peter Liese (Member of the European Parliament) and Verein Deutscher Zementwerke e.V.

12 Jan 2024 · Austausch

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and ReAct - Action on Antibiotic Resistance

8 Dec 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

3 Nov 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

3 Nov 2023

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

26 Sept 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on substantiation and communication of explicit environmental claims (Green Claims Directive)

20 Jul 2023

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 2 other interest representatives

6 Jul 2023 · Revision of Pharmaceutical Legislation (staff level)

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL concerning urban wastewater treatment (recast)

14 Mar 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

28 Jul 2022

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on Corporate Sustainability Due Diligence and amending Directive (EU) 2019/1937

23 May 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Proposal for a Regulation of the European Parliament and of the Council establishing a European Health Emergency Response Authority (HERA)

24 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

3 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

2 Feb 2021

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

30 Nov 2020 · Future of Medicines

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions "Making the most of EU’s innovative potential - An Intellectual Property action plan in support of the EU’s industrial competitiveness"

14 Aug 2020

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on health technology assessment and amending Directive 2011/24/EU

26 Mar 2018